Publicly Funded, Privately Locked: The Scandal of Research Americans Pay For But Cannot Read
Photo by Photo by Brett Jordan on Unsplash on Unsplash
Consider the following sequence of events. A federal agency—the National Institutes of Health, perhaps, or the National Science Foundation—awards a grant totaling several hundred thousand dollars to a research team at a public university. That funding comes from tax revenue collected from American workers, businesses, and families. The researchers conduct their study over several years, produce findings of genuine public significance, and submit a manuscript to a prestigious journal. The journal publishes the paper. And then, almost immediately, that paper disappears behind a paywall charging anywhere from $30 to $50 for a single 48-hour access window.
The taxpayer who funded the work cannot read it. The nurse practitioner in a rural clinic who might apply its findings cannot access it. The high school science teacher hoping to bring current research into the classroom is turned away. The research exists—but for most Americans, it might as well not.
The Scale of the Problem
This is not an edge case or an occasional inconvenience. It is the dominant mode through which American publicly funded research reaches—or fails to reach—the public.
The NIH distributes approximately $47 billion annually in research funding, making it the world's largest public funder of biomedical research. The NSF contributes an additional $9 billion or more each year across scientific disciplines. Together, these two agencies alone channel more than $56 billion of public money into research annually. Historically, the majority of work produced with this funding has been published in subscription-based journals controlled by a small number of large commercial publishers.
A landmark study published in the journal Science estimated that roughly 75 percent of scientific literature remains inaccessible without institutional subscriptions. While the NIH has maintained a public access policy since 2008—requiring that funded research be deposited in PubMed Central within 12 months of publication—that 12-month embargo period means that the most timely and consequential findings are withheld from public view precisely when they are most relevant.
During the COVID-19 pandemic, this structural failure became acutely visible. Research on viral transmission, vaccine efficacy, and treatment protocols was being produced at extraordinary speed—and much of it was locked away from the clinicians, public health workers, and informed citizens who needed it most urgently.
The Human Cost: Voices from the Field
The abstract figures acquire concrete weight when examined through the experiences of practitioners who encounter these barriers daily.
A family medicine physician practicing in rural Appalachia described spending hours attempting to access research on pain management protocols relevant to her patient population. "I don't have an academic affiliation anymore," she explained. "I trained at a university hospital, but in private practice, I'm on my own. If I want to read the latest research, I'm either paying out of pocket or I'm making clinical decisions without it."
A middle school science educator in suburban Ohio recounted attempting to incorporate recent climate research into a curriculum unit, only to find that every relevant primary source required institutional access he did not possess. "I ended up using secondhand summaries," he said. "My students deserved better than that. The research existed. We just couldn't get to it."
These are not isolated anecdotes. A survey conducted by the American Library Association found that more than 60 percent of public librarians reported regular patron requests for academic research that their institutions could not fulfill due to subscription barriers.
Where the Money Goes
Perhaps the most striking aspect of this system is the degree to which public funding flows not only into research production but into the coffers of private publishers who then restrict access to the resulting work.
When a federally funded researcher publishes in a major subscription journal, the journal typically receives the intellectual labor of the researcher (funded by grants), the peer review of other researchers (also often publicly funded), and in some cases, page or processing fees charged to the grant itself. The publisher then sells access back to universities—which are also frequently publicly funded—at prices that have increased at roughly four times the rate of inflation over the past three decades.
Profit margins for the largest academic publishers have been reported at levels that would be remarkable in any industry. Elsevier, for instance, has posted operating profit margins exceeding 35 percent in recent years. This profitability is built, in substantial part, on publicly funded inputs and publicly funded institutional customers.
The Open-Access Alternative
The contrast with European open-access publishing models is instructive. Across the European Union, major research funding bodies have implemented requirements that publicly funded research be made immediately and freely available upon publication. Plan S, launched in 2018 by a coalition of European research funders, mandates full and immediate open access for all funded outputs—with no embargo periods and no reader-facing paywalls.
Journals operating within this framework, many of which are indexed and freely accessible through platforms such as the Directory of Open Access Journals (DOAJ) and OpenAIRE, demonstrate that high-quality peer review and rigorous editorial standards are entirely compatible with free public access. The funding model shifts—from reader subscriptions to author-side processing charges or institutional support—but the knowledge itself flows freely.
The OSTP memorandum issued in August 2022 signaled a meaningful step toward a similar standard in the United States, requiring that all federally funded research be made publicly available without embargo by 2026. Implementation remains ongoing, and significant institutional resistance persists from commercial publishers with considerable lobbying resources.
A Question of Democratic Principle
At its core, the paywall problem is not merely a logistical inefficiency. It is a question of democratic accountability. When citizens fund scientific inquiry through their tax contributions, there is a reasonable expectation—arguably a moral claim—that the products of that inquiry should be accessible to them.
European frameworks have largely accepted this principle and built policy around it. The United States is moving, however haltingly, in the same direction. The open-access journals and repositories that have flourished under European funding models offer a working proof of concept: transparent, freely available scientific knowledge is not a utopian aspiration. It is an operational reality, already serving researchers, practitioners, and citizens across the Atlantic.
The question facing American research policy is not whether open access is achievable. It is whether the political will exists to prioritize public benefit over private profit in the dissemination of publicly funded knowledge.
